再創佳績:學院獲批研資局八項優配研究金

2026年7月3日

學院在研究資助局「優配研究金」2026/27 競逐中再創佳績,成功囊括八項研究撥款。獲資助項目數量連續兩年穩步攀升,充分彰顯學院在中醫藥科研領域的卓越實力與領先地位。

本年度獲資助的項目聚焦中醫藥、生物醫學和創新藥物研發等前沿領域,並貫徹跨學科研究的理念。相關研究深具轉化潛力,有望拓展嶄新治療策略,闡明創新藥物與療法的機制,推動整合醫學與疾病管理模式的發展。

院長李敏教授對學院科研人員的驕人成績深感自豪,她表示:「學院近年在校外競爭性資助中屢獲佳績,新晉研究人員表現尤其矚目,充分體現了學院的科研實力和人才培育成果廣獲學界肯定。」

展望未來,學院將繼續立足科研創新前沿,致力融合傳統中醫藥智慧與現代科學技術,為增進人類健康謀福祉作出更大貢獻。

 

由學院領導的2026/27優配研究金資助項目(只提供英文版)

Principal Investigator

Project Title

Professor Li Min

李敏教授

Investigating the Specific Roles of TFE3 in CAPON-Mediated Tauopathy in Alzheimer's disease and Therapeutic Potential of Corynoxine    

Professor Zhang Ge

張戈教授

Sclerostin-loop3-LRP4 interaction in adipocytes could be required by sclerostin to impair whole-body lipid/glucose metabolism

Professor Han Quanbin Simon

韓全斌教授

Investigating the Structure-Activity Relationships and Binding Interactions between polysaccharides and GP2/TLR4 receptors: Implications for Intestinal Lymphatic Absorption and Immune Modulation

Professor Cheung King-ho

張敬浩教授

Deciphering Genistein’s Neuroprotective

Professor Li Fangfei

李芳菲教授

Targeted Degradation of Nuclear uPA to Inhibit Perineural Invasion in Pancreatic Cancer via PROTAC Strategy

Dr. Li Lifeng Cherry

李利鋒博士

From a traditional pediatric remedy Goat Bezoar to functional food: Urolithins as a novel intervention for pediatric respiratory health

Dr. Chen Qilei

陳綺蕾博士

Investigating a novel synovial crosstalk: Fibroblast-like synoviocyte exosomal miRNAs drive pathogenic macrophage reprogramming in rheumatoid arthritis

Dr. Cheung Chat-pan Kenneth

張質彬博士

Investigating Hyodeoxycholic Acid as a Regulator of Immunometabolism in Rheumatoid Arthritis

 

20260703_1 20260703_1